The Role of Testosterone in Menopause Management: A Review of Literature
Background: Despite the lack of approved testosterone formulations for women in most countries, testosterone therapy is still being offered to women worldwide. Aging and loss of ovarian or adrenal function, among others, can lower testosterone levels in women. However, international guidelines curre...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2021-09-01
|
| Series: | Fertility & Reproduction |
| Subjects: | |
| Online Access: | http://www.worldscientific.com/doi/epdf/10.1142/S2661318221500110 |
| _version_ | 1818671404409683968 |
|---|---|
| author | Eileen M. Manalo Ina S. Irabon Shayne S. Fajutagana |
| author_facet | Eileen M. Manalo Ina S. Irabon Shayne S. Fajutagana |
| author_sort | Eileen M. Manalo |
| collection | DOAJ |
| description | Background: Despite the lack of approved testosterone formulations for women in most countries, testosterone therapy is still being offered to women worldwide. Aging and loss of ovarian or adrenal function, among others, can lower testosterone levels in women. However, international guidelines currently do not routinely recommend androgen replacement therapy due to lack of long-term safety data. Evidence on its benefits and risks still remains uncertain.
Objectives: The aim of this literature review is to present current studies and guidelines that examined the effects of testosterone therapy for postmenopausal women, including its role on cognition and mood; breast and endometrial cancer risks; musculoskeletal, cardiovascular, and genitourinary health; and sexual function.
Methodology: A review of literature was done using PubMed, EMBASE, Science Direct, OVID, and Google scholar, with the following key words: androgen, testosterone, menopause, and hypoactive sexual desire dysfunction. We identified reviews, clinical trials, and guidelines. The population was limited to postmenopausal women.
Results: There is no evidence from current published literature to support the use of testosterone therapy for female well-being, mood and cognition, bone and cardiovascular health. Intravaginal testosterone appears to be a promising alternative for the treatment of genitourinary symptoms of menopause (GSM) but efficacy and safety are yet to be confirmed. Well-designed, randomized, and placebo-controlled trials are needed to establish long-term safety, efficacy, and appropriate dosing and route of testosterone therapy in postmenopausal women. The only evidence-based indication for testosterone therapy in women is for the treatment of postmenopausal hypoactive sexual desire disorder (HSDD). Should a trial of testosterone therapy be given for HSDD, the transdermal route is the preferred method of delivery. Baseline total testosterone concentration should be determined before starting treatment, and repeated after 3–6 months. Serum testosterone levels should be monitored at regular intervals to avoid supraphysiologic dosing.
Conclusion: Currently, there is no robust evidence to support the use of exogenous testosterone to improve female well-being, musculoskeletal health, mood and cognition, as well as bone and cardiovascular health among postmenopausal women. The only evidence-based indication for testosterone therapy in women is the treatment of postmenopausal hypoactive sexual desire disorder, but only after all other causes of sexual dysfunction have been ruled out. To date, testosterone therapy has no US Food and Drug Administration (US FDA) approval due to the lack of long-term efficacy and safety data. |
| first_indexed | 2024-12-17T07:23:28Z |
| format | Article |
| id | doaj.art-4cbc5e5bd2ee412eabb8d73511920f88 |
| institution | Directory Open Access Journal |
| issn | 2661-3182 2661-3174 |
| language | English |
| last_indexed | 2024-12-17T07:23:28Z |
| publishDate | 2021-09-01 |
| publisher | World Scientific Publishing |
| record_format | Article |
| series | Fertility & Reproduction |
| spelling | doaj.art-4cbc5e5bd2ee412eabb8d73511920f882022-12-21T21:58:42ZengWorld Scientific PublishingFertility & Reproduction2661-31822661-31742021-09-0133889310.1142/S266131822150011010.1142/S2661318221500110The Role of Testosterone in Menopause Management: A Review of LiteratureEileen M. Manalo0Ina S. Irabon1Shayne S. Fajutagana2University of the Philippines — College of Medicine, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, PhilippinesUniversity of Perpetual Help Jonelta Foundation School of Medicine, Las Pinas City, PhilippinesSta. Ana Hospital, Manila, PhilippinesBackground: Despite the lack of approved testosterone formulations for women in most countries, testosterone therapy is still being offered to women worldwide. Aging and loss of ovarian or adrenal function, among others, can lower testosterone levels in women. However, international guidelines currently do not routinely recommend androgen replacement therapy due to lack of long-term safety data. Evidence on its benefits and risks still remains uncertain. Objectives: The aim of this literature review is to present current studies and guidelines that examined the effects of testosterone therapy for postmenopausal women, including its role on cognition and mood; breast and endometrial cancer risks; musculoskeletal, cardiovascular, and genitourinary health; and sexual function. Methodology: A review of literature was done using PubMed, EMBASE, Science Direct, OVID, and Google scholar, with the following key words: androgen, testosterone, menopause, and hypoactive sexual desire dysfunction. We identified reviews, clinical trials, and guidelines. The population was limited to postmenopausal women. Results: There is no evidence from current published literature to support the use of testosterone therapy for female well-being, mood and cognition, bone and cardiovascular health. Intravaginal testosterone appears to be a promising alternative for the treatment of genitourinary symptoms of menopause (GSM) but efficacy and safety are yet to be confirmed. Well-designed, randomized, and placebo-controlled trials are needed to establish long-term safety, efficacy, and appropriate dosing and route of testosterone therapy in postmenopausal women. The only evidence-based indication for testosterone therapy in women is for the treatment of postmenopausal hypoactive sexual desire disorder (HSDD). Should a trial of testosterone therapy be given for HSDD, the transdermal route is the preferred method of delivery. Baseline total testosterone concentration should be determined before starting treatment, and repeated after 3–6 months. Serum testosterone levels should be monitored at regular intervals to avoid supraphysiologic dosing. Conclusion: Currently, there is no robust evidence to support the use of exogenous testosterone to improve female well-being, musculoskeletal health, mood and cognition, as well as bone and cardiovascular health among postmenopausal women. The only evidence-based indication for testosterone therapy in women is the treatment of postmenopausal hypoactive sexual desire disorder, but only after all other causes of sexual dysfunction have been ruled out. To date, testosterone therapy has no US Food and Drug Administration (US FDA) approval due to the lack of long-term efficacy and safety data.http://www.worldscientific.com/doi/epdf/10.1142/S2661318221500110menopausetestosteroneandrogenhypoactive sexual desire dysfunction |
| spellingShingle | Eileen M. Manalo Ina S. Irabon Shayne S. Fajutagana The Role of Testosterone in Menopause Management: A Review of Literature Fertility & Reproduction menopause testosterone androgen hypoactive sexual desire dysfunction |
| title | The Role of Testosterone in Menopause Management: A Review of Literature |
| title_full | The Role of Testosterone in Menopause Management: A Review of Literature |
| title_fullStr | The Role of Testosterone in Menopause Management: A Review of Literature |
| title_full_unstemmed | The Role of Testosterone in Menopause Management: A Review of Literature |
| title_short | The Role of Testosterone in Menopause Management: A Review of Literature |
| title_sort | role of testosterone in menopause management a review of literature |
| topic | menopause testosterone androgen hypoactive sexual desire dysfunction |
| url | http://www.worldscientific.com/doi/epdf/10.1142/S2661318221500110 |
| work_keys_str_mv | AT eileenmmanalo theroleoftestosteroneinmenopausemanagementareviewofliterature AT inasirabon theroleoftestosteroneinmenopausemanagementareviewofliterature AT shaynesfajutagana theroleoftestosteroneinmenopausemanagementareviewofliterature AT eileenmmanalo roleoftestosteroneinmenopausemanagementareviewofliterature AT inasirabon roleoftestosteroneinmenopausemanagementareviewofliterature AT shaynesfajutagana roleoftestosteroneinmenopausemanagementareviewofliterature |